Movano

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Leabman in January 2018 and is headquartered in Pleasanton, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Movano Health reports revenue growth but faces operating loss in Q1 2024

Movano Health's Q1 2024 performance showed revenue from Evie Ring shipments but an operating loss, mitigated by a $24 million private placement. The company aims to optimize operations, secure FDA clearance, and expand partnerships to drive growth and profitability.

Movano Health advances FDA-cleared products, eyes clinical trials for growth

Movano Health's Q2 2024 earnings call highlighted progress, challenges, and opportunities in the health monitoring technology sector. With a focus on product development, marketing strategies, and capital management, Movano aims to drive growth and innovation in the market.

Movano (MOVE) excels in Q3 with Evie Ring success and growth prospects

Movano's Q3 performance reflects strong sales, operational improvements, and a strategic focus on product development and partnerships. While facing challenges in a competitive market and regulatory compliance, the company is well-positioned to capitalize on growth opportunities through innovation and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Movano Inc. (NASDAQ:MOVE ) Q4 2023 Results Conference Call April 4, 2024 5:00 PM ET Company Participants David Barnard - Senior Vice President of Investor Relations John Mastrototaro - CEO Michael Soule - VP of Business Development Jeremy Cogan - CFO & Secretary Michael Leabman - Founder, CTO & Director Tyla Bucher - Chief Marketing Officer Operator Greetings, and welcome to the Movano Health Fourth Quarter 2023 Earnings Call. [Operator Instructions].

Movano Inc. (MOVE) Q4 2023 Earnings Call Transcript

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of directors PLEASANTON, Calif. , April 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of directors.

Movano Health Closes $24 Million Private Placement

Executes $24 million funding extending cash runway  Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities  Plans launch of Evie Med  Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , April 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.

Movano Health Reports 2023 Financial Results and Provides Business Update

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting conference call on April 4, 2024 at 2:00 PM PT/5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and  members of the Company's management team and board of directors.

Movano Health Announces $24 Million Private Placement

The seed investment and agreement underscores Movano Health's multi-analyte and  proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and commercialization.

Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on Thursday, April 4, 2024, after the market close.

Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024

PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today.

Movano Health Announces Evie Rings Now Shipping

LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams OSRAMs PPG sensor solution in the Evie Ring, Movano Health's smart ring designed specifically for women. With the goal to bring high-quality data to the forefront of consumer health devices, Movano Health´s female-first wearable, the Evie Ring, is a personalized solution designed specifically for women that provides medical-grade data measurement of critical vitals for an on-demand understanding of overall health.

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring, is redefining the wearable category with a unique band design, female-specific data interpretation, and AI-based trend analysis that goes beyond raw activity scores to improve users' ability to understand and manage their health. Evie earned a 2024 CES Innovation Honoree Award, begins shipping this month, and was showcased over the weekend at CES Unveiled in Las Vegas.

Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level

PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/FSA fund reimbursement.

Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring

PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clinical trial it will be holding in person demonstrations of live waveforms at both the 2024 CES Show in Las Vegas January 8-11, 2024 and in conjunction with the JP Morgan Healthcare Conference in San Francisco January 9-10, 2024.

Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement

PLEASANTON, Calif. , Nov. 29, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company's commercial sales goals driving over $1 million in orders through the Thanksgiving Holiday.

Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement

Unique Design, Women-Focused Metrics and Cross-Data Trend Analysis Set a New Bar for Wearables PLEASANTON, Calif. , Nov. 20, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) begins taking orders for the Evie Ring, the smart ring designed specifically for women, today at 12 pm EST.

Evie, the Smart Ring for Women from Movano Health, Available for Order Today

PLEASANTON, Calif. , Nov. 17, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced the closing of its $4.1 million underwritten public offering of 4,870,600 shares of its common stock, including 635,296 shares of its common stock issued pursuant to the full exercise by the underwriter of its over-allotment option.

Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option

Movano Inc. (NASDAQ:MOVE ) Q3 2023 Earnings Conference Call November 15, 2023 11:30 AM ET Company Participants Jay Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyler Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President, Product and Strategy Operator Hello and welcome to Movano Health Third Quarter 2023 Earnings Call. I'd like to remind everyone that this call is being recorded and a replay of the call will be available on Movano Health's website, ir.movano.com.

Movano Inc. (MOVE) Q3 2023 Earnings Call Transcript

Conference call begins at 8:30 a.m. Pacific time today PLEASANTON, Calif.

Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results

PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its common stock.

Movano Health Prices $3.6 Million Public Offering

Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the  Evie Ring , today announced that, in light of the Company's recently announced proposed common stock offering, Movano Health has issued its Form 10-Q for the third quarter of 2023 and will report third quarter 2023 financial and operating results on Wednesday, November 15, 2023, before the equity markets open.

Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023

PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering.

Movano Health Announces Proposed Public Offering

PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report third quarter 2023 financial and operating results on Tuesday, November 14, 2023.

Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023

Leveraging the Company's 4 x 6.7 mm System-on-a-Chip (SoC), the clinical study results are a significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure device PLEASANTON, Calif. , Oct. 31, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced the results of its Institutional Review Board (IRB)-approved blood pressure clinical study.

Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring

The Company will begin taking orders for the smart ring designed for women's health through its commercial site www.eviering.com in time for Black Friday PLEASANTON, Calif. , Oct. 30, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced its launch plans for the Evie Ring, the smart ring designed for women's health.

Movano Health to Launch the Evie Ring on November 20

Dr. Rodriguez will provide strategic input and medical validation to guide innovation for the Evie Ring  PLEASANTON, Calif. , Sept. 12, 2023 /PRNewswire/ -- After recently announcing the establishment of its Medical Advisory Board, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today shared Dr. Fátima Rodriguez has joined as its newest member.

Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board

The Evie Ring, the first medical grade health wearable designed for women, will ship from FDAregistered fulfillment provider Jay Group    LANCASTER, Pa. , Aug. 30, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced the selection of advanced fulfillment provider, Jay Group, as its 3PL.

Movano Health, Maker of the Evie Ring, Selects Jay Group as its Fulfillment Provider in Preparation for its Commercial Launch

Movano Inc. (NASDAQ:MOVE ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jeremy Cogan - CFO & Secretary John Mastrototaro - CEO, President & Director Michael Aaron Leabman - Founder, CTO & Director Tyla Bucher - Chief Marketing Officer Conference Call Participants Marie Thibault - B. Riley Operator Greetings and welcome to the Movano Second Quarter 2023 Earnings Call.

News for Movano Stock (MOVE)